The results of clinical trials on two antiviral drugs to treat the coronavirus outbreak could be days away from being released, health officials said.

Dr. Marie-Paule Kieny, who co-chaired a World Health Organization meeting in Geneva this week, said a combination of the two drugs — ritonavir and lopinavir — has been used on a number of coronavirus patients in preliminary trials, but she could not provide an exact count.

“We don’t know the result, and we still have to wait for a few days, or a few weeks to have a result,” Kieny told the research forum Wednesday.

However, if the results are favorable, Kieny said it could quickly be implemented to treat patients since “this drug is available in particular as a generic formulation for the treatment of HIV, so this would clearly be a drug that would be available.”

The combination HIV therapy is sold under the brand name Kaletra by AbbVie Inc.

The new virus, officially known as COVID-19, has killed at least 1,367 people in China and sickened around 60,000 others.

With Post wires